^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ColoAlert

    Company:
    Mainz BioMed
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    ColoAlert is designed to detect tumor DNA and detect 85% of colorectal cancer cases - often in the earliest stages of the disease. ColoAlert detects bleeding and non-bleeding tumours through tumour DNA analysis and thus offers a better early detection than fecal occult blood tests.
    Cancer:
    Colorectal Cancer
    Method:
    PCR
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    06/01/22
    CRC
    -
    CE